Articles From: PSA Pilots Achieve a Tentative Agreement with Management to pSivida Reports on Resubmission to FDA of NDA for ILUVIEN® for Chronic Diabetic Macular Edema


2013/2/15
PSA pilots, represented by the Air Line Pilots Association, Int’l (ALPA), have reached a tentative agreement with PSA Airlines, a wholly owned subsidiary of US Airways Group, Inc. (NYSE:LCC) after nearly four years of negotiations.
Sign-up for PSA Pilots Achieve a Tentative Agreement with Management investment picks
2013/3/27
PSA pilots, represented by the Air Line Pilots Association, Int’l (ALPA), today ratified a tentative agreement reached with the management of PSA Airlines, a wholly owned subsidiary of US Airways Group, Inc. (NYSE:LCC) .
Sign-up for PSA Pilots Ratify New Collective Bargaining Agreement investment picks
2013/3/26
NEW YORK , March 26, 2013 /PRNewswire/ -- P.
Sign-up for PSAM Responds To MetroPCS Letter To Shareholders And Points Out Inaccuracies investment picks
2013/3/7
NEWARK, N.J. , March 7, 2013 /PRNewswire/ --   PSE&G urges New Jersey 's workforce members who are in financial difficulty to see if they are eligible for the 2012 Earned Income Tax Credit (EITC). This special credit reduces the amount of taxes owed by eligible workers and sometimes provides a tax refund as well.
Sign-up for PSE&G Encourages NJ's Working Families To Apply For Special Tax Credit investment picks
2013/3/20
Customer bills expected to remain steady while making necessary improvements to reduce outages NEWARK, N.J. , March 20, 2013 /PRNewswire/ -- Public Service Electric and Gas Company (PSE&G) today said the typical residential customer who receives both electric and gas from the utility is projected to pay about $12 less per year in 2018 than today if the utility gets approval for every project in its "Energy Strong" program to upgrade its electric and gas distribution systems.
Sign-up for PSE&G Files Rates For Energy Strong Program investment picks
2013/2/7
Additional crews and equipment on hand to restore service NEWARK, N.J. , Feb.
Sign-up for PSE&G Readies For Nor'easter investment picks
2013/2/4
Help is available to pay energy bills NEWARK, N.J. , Feb.
Sign-up for PSE&G Reminds Eligible Customers To Apply For Heating Assistance investment picks
2013/2/20
Proposal will create 5,800 jobs and reduce the impact of future outages Customer bills will remain stable - and will be lower than in 2008 NEWARK, N.J. , Feb.
Sign-up for PSE&G Unveils $3.9 Billion, 10-Year Proposal To Make NJ "Energy Strong" investment picks
2013/2/13
Hispanic customers again targeted NEWARK, N.J. , Feb.
Sign-up for PSE&G Warns Customers About Payment Scam investment picks
2013/4/11
SMALL BUSINESSES TARGETED NEWARK, N.J. , April 11, 2013 /PRNewswire/ -- PSE&G is urging its customers to be alert to a scam that is increasingly targeting small businesses.
Sign-up for PSE&G Warns Customers About Payment Scam investment picks
2013/3/22
NEWARK, N.J. , March 22, 2013 /PRNewswire/ -- PSE&G vice president Kim Hanemann , who is directing $3.6 billion of transmission infrastructure investments for the New Jersey utility during the next three years, has been named one of NJBIZ's 50 top women in business.
Sign-up for PSE&G's Kim Hanemann Named One of NJ's "Top Women in Business" investment picks
2013/4/30
Public Service Enterprise Group Inc.'s (PEG) first-quarter earnings fell 35%, partly due to storm-restoration costs, while the New Jersey utility company's revenue was weaker than expected.
Sign-up for PSEG 1st-Quarter Net Falls 35% as Revenue Continues to Slide investment picks
2013/2/21
Operating Earnings of $2.44 Per Share; Earnings from Continuing Operations of $2.51 Per Share Company Provides 2013 Guidance of $2.25 - $2.50 Per Share PSE&G Proposes 10-year Infrastructure Enhancement Program: $3.9 Billion on Distribution and $1.5 Billion on Transmission NEWARK, N.J. , Feb.
Sign-up for PSEG Announces 2012 Results investment picks
2013/4/30
Earnings from Continuing Operations of $0.63 Per Share; Operating Earnings of $0.85 Per Share Results Reflect Increased Investment at PSE&G and Strong Performance from PSEG Power PSE&G Reaches Agreement on Solar Investment Company Maintains 2013 Guidance of $2.25 - $2.50 Per Share NEWARK, N.J. , April 30, 2013 /PRNewswire/ -- Public Service Enterprise Group (PSEG) reported today Income from Continuing Operations and Net Income for the first quarter of 2013 of $320 million or $0.63 per share as compared to Income from Continuing Operations and Net Income of $493 million or $0.97 per share in the first quarter of 2012.
Sign-up for PSEG Announces 2013 First Quarter Results investment picks
2013/2/19
Annual rate goes to $1.44 from $1.42 per share NEWARK, N.J. , Feb.
Sign-up for PSEG Declares 1.4% Increase In Quarterly Dividend investment picks
2013/4/16
NEWARK, N.J. , April 16, 2013 /PRNewswire/ -- The board of directors of Public Service Enterprise Group (PSEG) has declared a quarterly dividend of 36-cents per share of common stock for the second quarter of 2013.
Sign-up for PSEG Declares 36-Cent Quarterly Dividend investment picks
2013/3/27
WOOD DALE, Ill., March 27, 2013 (GLOBE NEWSWIRE) -- Power Solutions International, Inc. (OTCBB:PSIX) , and Capacity of Texas, Inc .
Sign-up for PSI and Capacity Launch Medium-Duty Truck Collaboration at MATS 2013 investment picks
2013/2/19
WOOD DALE, Ill., Feb.
Sign-up for PSI Announces Launch of Retooled Website investment picks
2013/3/20
PsiOxus Therapeutics today issued a statement in response to initial results from Amgen's (Nasdaq: AMGN) phase III study of talimogene laherparepvec in patients with unresected stage IIIB, IIIC or IV metastatic melanoma compared to treatment with subcutaneous granulocyte-macrophage colony-stimulating factor (GM-CSF). Talimogene laherparepvec is a novel oncolytic vaccine that represents a new class of anticancer agents known as oncolytic vaccines.
Sign-up for PsiOxus Therapeutics Comments on Phase III Results from Amgen’s Oncolytic Vaccine investment picks
2013/4/10
pSivida Corp.
Sign-up for pSivida Announces Launch of New Online Corporate Communication Channels investment picks
2013/4/4
pSivida Corp.
Sign-up for pSivida Announces Tech Evaluation Agreement With Leading Global Pharmaceutical Company investment picks
2013/2/4
pSivida Corp.
Sign-up for pSivida CEO to Present at 15th Annual BioCEO & Investor Conference February 12 investment picks
2013/5/7
pSivida Corp.
Sign-up for pSivida Corp. Announces Commercial Launch of ILUVIEN® in Germany with First Patient Treated investment picks
2013/5/1
pSivida Corp.
Sign-up for pSivida Corp. Announces New ILUVIEN® PDUFA Date of October 17, 2013 investment picks
2013/2/6
pSivida Corp.
Sign-up for pSivida Corp. Reports Second Quarter Fiscal Year 2013 Results investment picks
2013/5/13
pSivida Corp.
Sign-up for pSivida Corp. Reports Third Quarter Fiscal Year 2013 Results investment picks
2013/4/29
pSivida Corp.
Sign-up for pSivida Reports ILUVIEN® Available in UK investment picks
2013/4/1
pSivida Corp.
Sign-up for pSivida Reports on Resubmission to FDA of NDA for ILUVIEN® for Chronic Diabetic Macular Edema investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: PSA Pilots Achieve a Tentative Agreement with Management to pSivida Reports on Resubmission to FDA of NDA for ILUVIEN® for Chronic Diabetic Macular Edema
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity